Authors:
MAHLER V
ANTONI C
ANHALT GJ
KOCH HJ
PETERS KP
MANGER B
KALDEN JR
HORNSTEIN OP
Citation: V. Mahler et al., GRAFT-VERSUS-HOST-LIKE MUCOCUTANEOUS ERUPTIONS WITH SEROLOGICAL FEATURES OF PARANEOPLASTIC PEMPHIGUS AND SYSTEMIC LUPUS-ERYTHEMATOSUS IN A PATIENT WITH NON-HODGKINS-LYMPHOMA, Dermatology, 197(1), 1998, pp. 78-83
Authors:
MAINI RN
BREEDVELD FC
KALDEN JR
SMOLEN JS
DAVIS D
MACFARLANE JD
ANTONI C
LEEB B
ELLIOTT MJ
WOODY JN
SCHAIBLE TF
FELDMANN M
Citation: Rn. Maini et al., THERAPEUTIC EFFICACY OF MULTIPLE INTRAVENOUS INFUSIONS OF ANTITUMOR NECROSIS FACTOR-ALPHA MONOCLONAL-ANTIBODY COMBINED WITH LOW-DOSE WEEKLYMETHOTREXATE IN RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 41(9), 1998, pp. 1552-1563
Authors:
KALDENNEMETH D
GREBMEIER J
ANTONI C
MANGER B
WOLF F
KALDEN JR
Citation: D. Kaldennemeth et al., NMR MONITORING OF RHEUMATOID-ARTHRITIS PATIENTS RECEIVING ANTI-TNF-ALPHA MONOCLONAL-ANTIBODY THERAPY, Rheumatology international, 16(6), 1997, pp. 249-255
Citation: C. Antoni, DUAL PROBLEMS AND SEPARATION OF SETS - LAGRANGE AND FENCHEL DUALITY, Journal of optimization theory and applications, 93(1), 1997, pp. 227-231
Authors:
ANTONI C
KAVANAUGH A
RASCU A
BRAAKMAN T
MANGER B
KALDEN J
Citation: C. Antoni et al., STANDARDIZATION OF JOINT EVALUATION PRIOR TO A MULTICENTER RHEUMATOID-ARTHRITIS (RA) TRIAL REDUCES VARIABILITY AMONG EXAMINERS, Arthritis and rheumatism, 40(9), 1997, pp. 386-386
Authors:
MAINI RN
BREEDVELD FC
KALDEN JR
SMOLEN JS
DAVIS D
MACFARLANE JD
ANTONI C
LEEB B
ELLIOTT MJ
WOODY JN
SCHAIBLE TF
FELDMANN M
Citation: Rn. Maini et al., LOW-DOSE METHOTREXATE (MTX) SUPPRESSES ANTI-GLOBULIN RESPONSES AND POTENTIATES EFFICACY OF A CHIMERIC MONOCLONAL ANTI-TNF-ALPHA ANTIBODY (CA2) GIVEN REPEATEDLY IN RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 40(9), 1997, pp. 571-571
Authors:
LORENZ HM
ANTONI C
VALERIUS T
REPP R
GRUNKE M
SCHWERDTNER N
NUSSLEIN H
WOODY J
KALDEN JR
MANGER B
Citation: Hm. Lorenz et al., IN-VIVO BLOCKADE OF TNF-ALPHA BY INTRAVENOUS-INFUSION OF A CHIMERIC MONOCLONAL TNF-ALPHA ANTIBODY IN PATIENTS WITH RHEUMATOID-ARTHRITIS - SHORT-TERM CELLULAR AND MOLECULAR EFFECTS, The Journal of immunology, 156(4), 1996, pp. 1646-1653
Authors:
KALDENNEMETH D
GREBMEIER J
ANTONI C
MANGER B
KALDEN JR
Citation: D. Kaldennemeth et al., A COMPUTERIZED AUTOMATED POST-PROCESSING MRI METHOD TO CONTROL SYNOVITIS IN PATIENTS WITH RHEUMATOID-ARTHRITIS UNDERGOING TREATMENT WITH BIOLOGICAL RESPONSE MODIFIERS, Arthritis and rheumatism, 39(9), 1996, pp. 446-446
Authors:
LORENZ HM
HIERONYMUS T
GRUNKE M
GEILER T
ANTONI C
WINKLER S
NUSSLEIN H
WOODY J
KALDEN JR
MANGER B
Citation: Hm. Lorenz et al., IN-VIVO BLOCKADE OF TNF-ALPHA IN PATIENTS WITH RHEUMATOID-ARTHRITIS -INDICATION FOR TACHYPHYLAXIS IN LONG-TERM EX-VIVO AND IN-VITRO EFFECTS AFTER REPEATED INFUSION OF CHIMERIC MONOCLONAL-ANTIBODY CA2, Arthritis and rheumatism, 39(9), 1996, pp. 1297-1297
Authors:
ANTONI C
MANGER B
REICHSTETTER S
SMOLEN J
BREEDVELD F
MAINI R
BIJL H
DEWOODY K
KALDEN J
WASSMUTH R
Citation: C. Antoni et al., THE HLA DR LOW AND DR4 HIGH-RESOLUTION BACKGROUND OF 55 PATIENTS WITHRHEUMATOID-ARTHRITIS TREATED WITH CA2 ANTIBODY AGAINST TUMOR-NECROSIS-FACTOR IN A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Arthritis and rheumatism, 39(9), 1996, pp. 1298-1298
Authors:
ELLIOTT MJ
MAINI RN
FELDMANN M
KALDEN JR
ANTONI C
SMOLEN JS
LEEB B
BREEDVELD FC
MACFARLANE JD
BIJL H
WOODY JN
Citation: Mj. Elliott et al., RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TOTUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS, Lancet, 344(8930), 1994, pp. 1105-1110
Authors:
WOITH W
NUSSLEIN I
ANTONI C
DEJICA DI
WINKLER TH
HERRMANN M
PIRNER K
KALDEN JR
MANGER B
Citation: W. Woith et al., A SOLUBLE FORM OF THE HUMAN TRANSFERRIN RECEPTOR IS RELEASED BY ACTIVATED LYMPHOCYTES INVITRO, Clinical and experimental immunology, 92(3), 1993, pp. 537-542